Use of Therapeutic Drug Monitoring, Electronic Health Record Data, and Pharmacokinetic Modeling to Determine the Therapeutic Index of Phenytoin and Lamotrigine
Lawrence Ku(Center for Drug Evaluation and Research), Wenlei Jiang(United States Food and Drug Administration), Huali Wu(Duke University), Jeffrey T. Guptill(Duke University), Chiara Melloni, Kevin D. Hill(Duke University), Alysha Berezny(Duke University), Daniel González(University of North Carolina at Chapel Hill), Christoph P. Hornik(Duke University), Nan Zheng, Rachel G. Greenberg(Duke University), Michael Cohen‐Wolkowiez(Duke University)
Cited by 0
Related Papers
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
|The Lancet|2018|1.8k
Significance of Protein Binding in Pharmacokinetics and Pharmacodynamics
|Journal of Pharmaceutical Sciences|2009|337
A Randomized, Double-blind, Multicenter Trial Comparing Efficacy and Safety of Imipenem/Cilastatin/Relebactam Versus Piperacillin/Tazobactam in Adults With Hospital-acquired or Ventilator-associated Bacterial Pneumonia (RESTORE-IMI 2 Study)
|Clinical Infectious Diseases|2020|232